Clinical Trial Update: Safety and Immunogenicity of the Malaria Vaccine, R21/MatrixM, in Healthy Thai Adults [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and immunogenicity of the R21/Matrix-M malaria vaccine in healthy Thai adults has completed. Results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Malaria

Drugs mentioned

• R21/Matrix-M malaria vaccine (R21/Matrix-M malaria vaccine)

Snippet

Sponsor: University of Oxford | Conditions: Malaria,Falciparum | Phase 2 | Status: COMPLETED | Results posted: 2025-07-03